Impact of Lebanon’s Economic Crisis on Cancer Care Delivery: A Multicenter Cross-Sectional Study of Treatment Initiation Delays and Incomplete Therapy
Current Oncology · 14.08.2026 · 33 (8) · 478
DOI: 10.3390/curroncol33080478 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Current Oncology, online erschienen am 14.08.2026. Verfasst von Mohamad Ali Hachem und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Hematology and Oncology, Faculty of Medical Sciences, Lebanese University, Beirut P.O. Box 14-6573, Leba…. Hauptthemen laut MEDLINE: Neoplasms, Economic Recession, Delivery of Health Care. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Roche Pharmaceuticals, Roche Real-World Data/Evidence (RWD/E) Award 2023.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background/Objectives: In Lebanon, the economic crisis since 2019 has severely strained healthcare infrastructure, yet its impact on cancer treatment adherence remains incompletely characterized. This study assessed factors associated with treatment delay and regimen modification to identify barriers to optimal cancer care among Lebanese patients.
Methods
This multicenter, cross-sectional study was conducted in five tertiary hospitals in Beirut, Lebanon, between 13 June 2024, and 27 June 2025. Demographic, clinical and treatment data were collected via a structured questionnaire. Bivariate and multivariable binary logistic regression analyses were performed to identify independent predictors of treatment delay (>2 weeks) and incomplete treatment regimens. Adjusted odds ratios (aORs) with 95% confidence intervals (CIs) are reported.
Results
A total of 244 patients were enrolled in the study. The study population was predominantly female (59.0%) and aged ≥60 years (60.2%). Advanced disease was common, with 50.4% of patients presenting with stage IV disease. Financial vulnerability was widespread: 72.6% reported monthly household incomes below USD 1000, 88.1% reported a decline in income due to the economic crisis, and 39.3% relied on unstable income sources. Overall, 52.5% of patients experienced treatment initiation delays, and 9.0% received incomplete or dose-reduced regimens. On multivariable analysis, reliance on unfixed income independently predicted treatment delay (aOR 2.55, 95% CI 1.42–4.59; p = 0.002), lack of health insurance (aOR 1.91, 95% CI 1.08–3.39; p = 0.026) and pre-treatment surgical costs also increased the odds of delay (aOR 9.03, 95% CI 2.57–31.7; p = 0.001). For incomplete treatment, unfixed income remained an independent predictor (aOR 2.09, 95% CI 1.16–5.79; p = 0.015). A lack of insurance (aOR 5.62, 95% CI 1.22–25.9; p = 0.027) and high laboratory costs (>USD 150 per session) were also associated with incomplete regimens (aOR 1.62, 95% CI 1.02–2.57; p = 0.041).
Conclusions
In Lebanon’s crisis context, financial instability was a key factor associated with deviations in cancer treatment. These findings highlight the need for strengthened insurance coverage and subsidization of diagnostic and treatment-related costs to ensure timely and continuous oncologic care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Hematology and Oncology, Faculty of Medical Sciences, Lebanese University, Beirut P.O. Box 14-6573, Lebanon.
- International Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France.
- Organized Research Unit, Al Zahraa Hospital University Medical Center, Beirut P.O. Box 90-361, Lebanon.
- Internal Medicine Department, Faculty of Medical Sciences, Lebanese University, Beirut P.O. Box 14-6573, Lebanon.
- Department of Hematology and Oncology, Lebanese Hospital Geitaoui-University Medical Center, Beirut, Lebanon.
- Department of Hematology and Oncology, Makassed General Hospital, Beirut P.O. Box 11-6301, Lebanon.
ORCID-Profile: Mohamad Ali Hachem, Nadeen Zayour, Elie Daibess, Elie Jean Karam, Zeinab Hammoud, Ghadir M Nasreddine, Bassam Matar
Förderung
- Roche Pharmaceuticals
- Roche Real-World Data/Evidence (RWD/E) Award 2023
Zitieren
APA
Hachem, M. A., Zayour, N., Daibess, E., Najjar, J., Karam, E. J., Farhat, S., Hammoud, Z., Nasreddine, G. M., Abbass, M., Sleiman, Z., Sadek, M., Ibrahim, A., Chehade, I., & Matar, B. (2026). Impact of Lebanon’s Economic Crisis on Cancer Care Delivery: A Multicenter Cross-Sectional Study of Treatment Initiation Delays and Incomplete Therapy. Current Oncology, 33(8), 478. https://doi.org/10.3390/curroncol33080478
Vancouver
Hachem MA, Zayour N, Daibess E, Najjar J, Karam EJ, Farhat S, et al. Impact of Lebanon’s Economic Crisis on Cancer Care Delivery: A Multicenter Cross-Sectional Study of Treatment Initiation Delays and Incomplete Therapy. Current Oncology. 2026;33(8):478. doi:10.3390/curroncol33080478
BibTeX
@article{Hachem2026,
author = {Hachem, Mohamad Ali and Zayour, Nadeen and Daibess, Elie and Najjar, Jacqueline and Karam, Elie Jean and Farhat, Solay and Hammoud, Zeinab and Nasreddine, Ghadir M and Abbass, Mohamad and Sleiman, Zeinab and Sadek, Maroun and Ibrahim, Ahmad and Chehade, Issam and Matar, Bassam},
title = {Impact of Lebanon’s Economic Crisis on Cancer Care Delivery: A Multicenter Cross-Sectional Study of Treatment Initiation Delays and Incomplete Therapy},
journal = {Current Oncology},
year = {2026},
volume = {33},
number = {8},
pages = {478},
doi = {10.3390/curroncol33080478}
}
EUVIMED